This paper is in the following e-collection/theme issue:

Electronic/Mobile Data Capture, Internet-based Survey & Research Methodology (841) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (158) Secondary Use of Clinical Data for Research and Surveillance (373) Surveillance Systems (464) Vaccination and Immunization in the Digital Age (378) HPV Vaccination (55)

Published on in Vol 22, No 6 (2020): June

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/17446, first published .
Active Surveillance of Adverse Events Following Human Papillomavirus Vaccination: Feasibility Pilot Study Based on the Regional Health Care Information Platform in the City of Ningbo, China

Active Surveillance of Adverse Events Following Human Papillomavirus Vaccination: Feasibility Pilot Study Based on the Regional Health Care Information Platform in the City of Ningbo, China

Active Surveillance of Adverse Events Following Human Papillomavirus Vaccination: Feasibility Pilot Study Based on the Regional Health Care Information Platform in the City of Ningbo, China

Authors of this article:

Zhike Liu1 Author Orcid Image ;   Liang Zhang2 Author Orcid Image ;   Yu Yang3 Author Orcid Image ;   Ruogu Meng3 Author Orcid Image ;   Ting Fang2 Author Orcid Image ;   Ying Dong2 Author Orcid Image ;   Ning Li2 Author Orcid Image ;   Guozhang Xu2 Author Orcid Image ;   Siyan Zhan1 Author Orcid Image
Article Authors Cited by (22) Tweetations (2) Metrics

Journals

  1. Xu X, Wang Y, Liu Y, Yu Y, Yang C, Zhang Y, Hong Y, Wang Y, Zhang X, Bian R, Cao X, Xu L, Hu S, Zhao F. A nationwide post-marketing survey of knowledge, attitudes and recommendations towards human papillomavirus vaccines among healthcare providers in China. Preventive Medicine 2021;146:106484 View
  2. Liu Z, Meng R, Yang Y, Li K, Yin Z, Ren J, Shen C, Feng Z, Zhan S. Active Vaccine Safety Surveillance: Global Trends and Challenges in China. Health Data Science 2021;2021:1 View
  3. Liu Z, Meng R, Yang Y, Li K, Yin Z, Ren J, Shen C, Feng Z, Zhan S. Progress of Active Surveillance for Vaccine Safety in China. China CDC Weekly 2021;3(27):581 View
  4. Li J, Zheng H, Duan X. Factors Influencing the Popularity of a Health-Related Answer on a Chinese Question-and-Answer Website: Case Study. Journal of Medical Internet Research 2021;23(9):e29885 View
  5. Deng S, Liu Z, Yang J, Zhang L, Shou T, Zhu J, He Y, Ma R, Li N, Xu G, Zhan S. Diagnostic validation and development of an algorithm for identification of intussusception in children using electronic health records of Ningbo city in China. Expert Review of Vaccines 2023;22(1):307 View
  6. Yang T, Ma R, Ye L, Mei Q, Wang J, Feng Y, Zhou S, Pan X, Hu D, Zhang D. Risk of peripheral facial palsy following parenteral inactivated influenza vaccination in the elderly Chinese population. Frontiers in Public Health 2023;11 View
  7. Xu L, Li N, Zhang L, Ma R, Fang T, Liu Z, Zhan S. Febrile Seizures and Measles-Containing Vaccines in China: A Self-Controlled Case Series Study. Vaccines 2021;9(10):1073 View
  8. Xu L, Li N, Zhang L, Ma R, Fang T, Liu Z, Zhan S. Lack of association between febrile seizures and vaccines containing diphtheria, tetanus, and acellular pertussis in Chinese children. Expert Opinion on Drug Safety 2023;22(3):253 View
  9. Sun Y, Zhang L, Li N, Zhao H, Ma R, Fang T, Yang T, Xu G, Liu Z, Zhan S. No association between enterovirus 71 (EV71) vaccination and risk of febrile seizures: a population-based near real-time surveillance study. Expert Review of Vaccines 2022;21(1):125 View
  10. Liu C, Lee W. Bilateral Optic Neuritis after COVID-19 Vaccination: A Case Report. Vaccines 2022;10(11):1889 View
  11. Xie H, Zhu H, Jiang N, Yin Y. Awareness of HPV and HPV vaccines, acceptance to vaccination and its influence factors among parents of adolescents 9 to 18 years of age in China: A cross-sectional study. Journal of Pediatric Nursing 2023;71:73 View
  12. Deng S, Welby S, Liu Z, Yang Y, Meng R, Sun Y, Yang J, Liu G, He Y, Jiang N, Wu Z, Liu K, Rosillon D, Cohet C, Borys D, Zhan S. MOnitoring human papillomavirus Vaccine effect on Infection and cErvical diseases (MOVIE): Protocol for a cohort study using electronic health records from Yinzhou, China. Human Vaccines & Immunotherapeutics 2023;19(2) View
  13. Liu Z, Li N, Liu G, Xu L, Dong Y, Meng R, Yang Y, Zhan S. No increased risk of intussusception after pentavalent rotavirus vaccination in China: a retrospective birth cohort using electronic health records of Ningbo city. Emerging Microbes & Infections 2023;12(2) View
  14. Welby S, Feng Y, Tang H, Ye C, Cohet C. A feasibility assessment of real‐world data capabilities for monitoring vaccine safety and effectiveness in China: Human papillomavirus vaccination in the Yinzhou district as a use case. Pharmacoepidemiology and Drug Safety 2023;32(10):1131 View
  15. Meng R, Ma R, Wang J, Liu P, Liu Z, He B, Liu Z, Yang Y, Zhan S. Post-marketing surveillance for the safety of the 9-valent human papillomavirus vaccine: a retrospective real-world study in China. Expert Review of Vaccines 2023;22(1):696 View
  16. Xiao Y, Chen Y, Huang R, Jiang F, Zhou J, Yang T. Interpretable machine learning in predicting drug-induced liver injury among tuberculosis patients: model development and validation study. BMC Medical Research Methodology 2024;24(1) View
  17. Qian Y, Zhao Y, Tang L, Ye D, Chen Q, Zhu H, Ye H, Xu G, Liu L. Short-term effects of air pollutants and meteorological factors on outpatients with allergic airway disease in Ningbo, China, 2015–2021. Public Health 2024;236:52 View
  18. Gào X, Sun Y, Shen P, Guo J, Chen Y, Yin Y, Liu Z, Zhan S. Population-Based Influenza Vaccine Effectiveness Against Laboratory-Confirmed Influenza Infection in Southern China, 2023–2024 Season. Open Forum Infectious Diseases 2024;11(9) View
  19. Yang Y, Zhang L, Hartwig S, Jiang P, Zhao H, Meng R, Liu Z, Liu Z, Ding K, You X, Koro C, Xu G, Zhan S. Post-marketing study design to evaluate the effectiveness of the 9-valent and 4-valent HPV vaccines on serious HPV-related cervical disease in China. Human Vaccines & Immunotherapeutics 2024;20(1) View
  20. Sun C. Case report: Satralizumab therapy for bilateral refractory optic neuritis following the first dose of bivalent human papilloma virus vaccine. Frontiers in Immunology 2024;15 View
  21. Liu Y, Chen X, Lin H, Shen P, Sun F, Xu Y. Early Rhythm Control Strategy in Early Atrial Fibrillation Patients. International Heart Journal 2024;65(6):1012 View

Books/Policy Documents

  1. Yang Y, Xu Y, Zhan S. Progress in China Epidemiology. View